Electrocardiographic imaging (ECGI), a novel diagnostic modality used for mapping of focal left ventricular tachycardia in a young athlete
Received 26 May 2005; accepted 17 August 2005. published online 03 September 2005.
We report the first clinical application of electrocardiographic imaging (ECGI), a new, noninvasive imaging modality for arrhythmias, in an athlete with focal ventricular tachycardia (VT) originating from a left ventricular (LV) diverticulum. A reconstructed map of the epicardial activation sequence during a single premature ventricular complex (PVC) of an identical QRS morphology to the clinical VT, generated from 224-electrode body surface ECGs and a chest CT (ECGI), localized the PVC to the site of the diverticulum. This correlated with subsequent maps obtained using standard techniques. We describe the first case that used ECGI to guide diagnosis and therapy of a clinical tachyarrhythmia.
aDepartment of Medicine (Cardiology), Case Western Reserve University/University Hospitals of Cleveland, Cleveland, Ohio
bDepartment of Radiology, Case Western Reserve University/University Hospitals of Cleveland, Cleveland, Ohio
cDepartment of Biomedical Engineering, Case Western Reserve University/University Hospitals of Cleveland, Cleveland, Ohio
dCardiovascular Center Aalst/OLV Hospital, Aalst, Belgium
eDepartment of Medicine (Cardiology) Brigham and Women’s Hospital, Boston, Massachusetts
fPresent affiliation: Cardiac Bioelectricity and Arrhythmia Center, Washington University in St. Louis, St. Louis, Missouri
Address reprint requests and correspondence: Albert L Waldo, MD, Division of Cardiology, University Hospitals of Cleveland, 11100 Euclid Avenue, Cleveland, Ohio 44106
The other authors have no conflict of interest to disclose.
EDITOR’S NOTE: Although case reports are limited to four authors, we made an exception in this case because of its complexity and the need for collaboration among multiple experts.
1 Authors Ping Jia and Charulatha Ramanathan are employees and stockholders of CardioInsight, Inc., a company that plans to commercialize electrocardiographic imaging as a clinical tool